146 results on '"Xu, Jiuyang"'
Search Results
2. Mechanisms of long COVID: An updated review
3. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
4. Distinct roles for type I and type III interferons in virulent human metapneumovirus pathogenesis
5. Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
6. Chronic active SARS-CoV-2 in B-cell immunodeficiency
7. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
8. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study
9. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19
10. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
11. Development and optimization of a direct plaque assay for trypsin-dependent human metapneumovirus strains
12. Pulmonary Mucormycosis with Rib Involvement in an Immunocompromised Patient
13. Appropriate use of antimicrobials in primary healthcare facility: a long way to go
14. Airway-invasion-associated pulmonary computed tomography presentations characteristic of invasive pulmonary Aspergillosis in non-immunocompromised adults: a National Multicenter Retrospective Survey in China
15. COVID-19 Pandemic: End of emergency, but not end of challenge
16. Respiratory viral infections in the elderly: From the perspective of the aging immune system
17. Improved response inhibition induced by attentional capture is associated with physical activity
18. Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study
19. The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis
20. Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
21. Response
22. Risk Factors of Viral RNAaemia and Its Association With Clinical Prognosis Among Patients With Severe Coronavirus Disease 2019
23. Risk Factors of Viral RNAaemia and Its Association With Clinical Prognosis Among Patients With Severe COVID-19
24. Antibody Responses and Clinical Outcomes in Adults Hospitalized with Severe COVID-19: A Post hoc Analysis of LOTUS China Trial
25. Letter from China: Managing the second‐wave COVID‐19 outbreak in Beijing
26. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
27. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
28. Viral pneumonia in China: from surveillance to response
29. The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis
30. Remdesivir and COVID-19 – Authors' reply
31. Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial
32. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study
33. Mendelian randomization in COVID-19: Applications for cardiovascular comorbidities and beyond
34. Influenza Virus in Community-Acquired Pneumonia: Current Understanding and Knowledge Gaps
35. Guarding a city from the COVID-19 pandemic
36. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
37. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
38. SARS-CoV-2 and viral sepsis: observations and hypotheses
39. A Novel Coronavirus (COVID-19) Outbreak
40. 2019 novel coronavirus outbreak: a quiz or final exam?
41. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
42. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
43. Cross-Reactive Antibody Against Human Coronavirus OC43 Spike Protein Correlates with Disease Severity in COVID-19 Patients: A Retrospective Study
44. 975. Roles of Type I and III Interferon in Severe Pathogenesis of Human Metapneumovirus
45. The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis.
46. Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial.
47. Immunoprotection versus immunopathology by type I and III interferon against human metapneumovirus
48. Antibodies and vaccines against Middle East respiratory syndrome coronavirus
49. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
50. Type I and III interferon signaling contributes to severe pathogenesis of human metapneumovirus clinical isolates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.